Pavlick Covers Research in BRAF Wild-Type Metastatic Melanoma

Source: Targeted Oncology, November 2019

During a Targeted Oncology live case-based peer perspectives live discussion, Anna C. Pavlick, DO, MS, explained to a group of physicians best practices for the diagnosis and management of patients with metastatic melanoma. Pavlick, co-director of the Melanoma Program and assistant director of the  Clinical Research Education at NYU Perlmutter Cancer Center, discussed treatment options between immunotherapy and targeted therapy based on the case scenario of a patient with BRAF wild-type metastatic melanoma

Read the original full article